SecBot SecBot
8-K ·Filed Jun 30, 2026

IMNN

Imunon, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed3mo ago SEC0001493152-26-031292
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any subsequent material developments in Imunon's pipeline or financial position. The CFO change alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
IMNN ▼ -28.19% at T+60d
NEUTRAL call -28.19% · α vs SPY -31.06% · entry $1.88 → $1.35
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+1.60%
call +1.60% · α +1.73%
$1.91
settled 4mo ago
T+5d
+3.72%
call +3.72% · α +3.46%
$1.95
settled 4mo ago
T+20d
-18.09%
call -18.09% · α -15.90%
$1.54
settled 3mo ago
T+60d
-28.19%
call -28.19% · α -31.06%
$1.35
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Imunon's interim CFO Jeffrey Church is retiring effective July 1, 2026, and will remain as a consultant at a $10,000 monthly retainer. The company appointed Josh Blacher as the new interim CFO via a master services agreement with Danforth Health, Inc. at a rate of $475 per hour. This is a routine CFO transition with no reported disagreements, and a successor was named, making the event neutral.

Key Facts

  • Interim CFO Jeffrey Church to retire effective July 1, 2026
  • Church will continue as consultant at $10,000/month retainer
  • Josh Blacher appointed as new interim CFO effective July 1, 2026
  • Blacher engaged through Danforth Health, Inc. at $475 per hour
  • Transition described as retirement without disagreements with management

Financial Impact

None — CFO transition is administrative; consulting retainer of $10,000/month and hourly rate of $475 are immaterial for an $8M market cap company.

Risk Factors

  • Potential disruption from CFO transition if consulting role fails to smooth handover
  • No operational or financial catalysts announced alongside this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-031292
Document: 0001493152-26-031292-index-headers.html0001493152-26-031292
Document: 0001493152-26-031292-index.html0001493152-26-031292
Document: 0001493152-26-031292.txt0001493152-26-031292
13 reports for IMNN
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +23.81%Jun 4, 2026
Filters
Rows
Reports for IMNN — sortable, filterable
TypeNow
Oct 27, 2026
today
S-1
BEARISH ★ 6/10
$1.22awaiting T+5—$1.23 (−0.82%)
Oct 27, 2026
today
8-K
NEUTRAL ★ 2/10
$1.25awaiting T+5—$1.23 (−1.60%)
Oct 21, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$1.19awaiting T+5—$1.23 (+3.36%)
Sep 29, 2026
27d ago
8-K
BEARISH ★ 5/10
$1.34 $1.12▲ +16.10%▲ +18.05%$1.23 (+7.87%)
Aug 11, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$1.61 $1.58▼ −1.86%▼ −1.42%$1.23 (−23.60%)
Aug 11, 2026
10w ago
8-K
NEUTRAL ★ 5/10
$1.61 $1.58▼ −1.86%▼ −1.46%$1.23 (−23.60%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$1.88 $1.95▲ +3.72%▲ +3.46%$1.23 (−34.57%)
Jun 16, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$1.86 $1.73▼ −6.99%▼ −5.95%$1.23 (−33.87%)
Jun 4, 2026
20w ago
8-K
BEARISH ★ 6/10
$2.10 $2.03▲ +3.33%▲ +0.78%$1.23 (+41.43%)
May 12, 2026
23w ago
8-K
BULLISH ★ 6/10
$2.70 $2.26▼ −16.30%▼ −16.37%$1.23 (−54.44%)
Showing 10 of 13

US Market Status

Market Closed — Opens in 2h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026